Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|June 6, 2024
Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in JapanRyota Hase, Aki Sakurai, Masahiro Suzuki, et al.
International Journal of Epidemiology|December 11, 2021
Smoking and severe illness in hospitalized COVID-19 patients in JapanYumi Matsushita, Tetsuji Yokoyama, Kayoko Hayakawa, et al.
Journal of Epidemiology|July 19, 2022
We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years OlderYumi Matsushita, Tetsuji Yokoyama, Kayoko Hayakawa, et al.
BMC Oral Health|August 22, 2018
Association between tooth loss and cognitive impairment in community-dwelling older Japanese adults: a 4-year prospective cohort study from the Ohasama studySho Saito, Takashi Ohi, Takahisa Murakami, et al.
Internal Medicine (Tokyo, Japan)|October 1, 2020
Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung CancerShunichi Nishima, Akihiko Miyanaga, Sho Saito, et al.
Life (Basel, Switzerland)|March 29, 2023
Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm StudyNoriko Tomita, Eriko Morino, Junko Terada-Hirashima, et al.
Life (Basel, Switzerland)|November 25, 2023
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered IndividualsMari Terada, Sho Saito, Satoshi Kutsuna, et al.
Infectious Disease Modelling|August 10, 2022
Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19Nobuaki Matsunaga, Keisuke Kamata, Yusuke Asai, et al.
Gerontology|January 9, 2022
Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in JapanYusuke Asai, Hidetoshi Nomoto, Kayoko Hayakawa, et al.
Heliyon|February 2, 2024
High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activityNoriko Iwamoto, Yuki Takamatsu, Yusuke Asai, et al.
Pageof 11